Literature DB >> 769466

The effect of cyproterone acetate on the plasma gonadotrophin response to gonadotrophin releasing hormone.

R A Donald, E A Espiner, R J Cowles, J E Fazackerley.   

Abstract

Cyporterone acetate (100-150 mg daily) was administered to 8 male patients with excessive libido. Within 3 months a significant fall (P less than 0.02) in plasma testosterone was demonstrated. The plasma luteinising hormone (LH) and follicle stimulatin hormone (FSH) responses to gonadotrophin releasing hormone (LH/FSH-RH) were also significantly impaired (P less than 0.05). A direct correlation between the resting plasma testosterone level and the LH response to LH/FSH-RH was demonstrated (r = 0.743). It is concluded that the fall inplasma testosterone levels in patients receiving cyproterone acetate may be attributed to suppression of LH release, rather than an antiandrogen effect on the testis or hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 769466     DOI: 10.1530/acta.0.0810680

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

1.  Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.

Authors:  G Valenti; P P Vescovi; G Gerra; G Rastelli; U Butturini
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

2.  Effect of cyproterone acetate on adrenocortical function in children with precocious puberty.

Authors:  D C Savage; P G Swift
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

3.  Modeling the synergistic properties of drugs in hormonal treatment for prostate cancer.

Authors:  Trevor Reckell; Kyle Nguyen; Tin Phan; Sharon Crook; Eric J Kostelich; Yang Kuang
Journal:  J Theor Biol       Date:  2021-01-07       Impact factor: 2.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.